Hyaluronan induces migration of multidrug-resistant lymphoma cell lines in vitro through Tiam1 activation by a PI3K-dependent mechanism

Leukemia Research

Volumn 34, Issue 11, 2010, Pages 1525-1532

  Cordo Russo, Rosalía I ^a   Alaniz, Laura D ^b   Saccodossi, Natalia ^a   Lompardía, Silvina ^a   Blanco, Guillermo ^a   Álvarez, Élida ^a   García, Mariana G ^a,b   Hajos, Silvia E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

Hyaluronan; Lymphoma; Migration; Multidrug resistance; Tiam1

Indexed keywords

CHEMOATTRACTANT; DOXORUBICIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HYALURONIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; T LYMPHOMA INVASION AND METASTASIS 1; UNCLASSIFIED DRUG; VINCRISTINE; TIAM1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CELL ASSAY; CELL FRACTIONATION; CELL INTERACTION; CELL MEMBRANE RESISTANCE; CELL MEMBRANE TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOLIC FRACTION; DRUG SENSITIVITY; ENZYME INHIBITION; ENZYME MECHANISM; IN VITRO STUDY; LYMPHOCYTE MIGRATION; LYMPHOMA CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; DRUG EFFECTS; LYMPHOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DRUG RESISTANCE, MULTIPLE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HYALURONIC ACID; LYMPHOMA; MICE; SIGNAL TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 77957020564     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.02.020     Document Type: Article

References (50)

1. Gottesman M.M., Ling V. The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 2006, 580:998-1009.
2. Bellacosa A., Kumar C.C., Di Cristofano A., Testa J.R. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 2005, 94:29-86.
3. Mashima T., Tsuruo T. Defects of the apoptotic pathway as therapeutic target against cancer. Drug Resist Updat 2005, 8:339-343.
4. Luciani F., Molinari A., Lozupone F., Calcabrini A., Lugini L., Stringaro A., et al. P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin. Blood 2002, 99:641-648.
5. Li Z.W., Dalton W.S. Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev 2006, 20:333-342.
6. Johnson P., Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 2009, 8:208-220.
7. Toole B.P. Hyaluronan in morphogenesis. Semin Cell Dev Biol 2001, 12:79-87.
8. Jiang D., Liang J., Noble P.W. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007, 23:435-461.
9. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004, 4:528-539.
10. Boregowda R.K., Appaiah H.N., Siddaiah M., Kumarswamy S.B., Sunila S., Thimmaiah K.N., et al. Expression of hyaluronan in human tumor progression. J Carcinog 2006, 5:2.
11. Itano N., Kimata K. Altered hyaluronan biosynthesis in cancer progression. Semin Cancer Biol 2008, 18:268-274.
12. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003, 4:33-45.
13. Naor D., Wallach-Dayan S.B., Zahalka M.A., Sionov R.V. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol 2008, 18:260-267.
14. Bourguignon L.Y. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol 2008, 18:251-259.
15. Minard M.E., Kim L.S., Price J.E., Gallick G.E. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat 2004, 84:21-32.
16. Habets G.G., Scholtes E.H., Zuydgeest D., van der Kammen R.A., Stam J.C., Berns A., et al. Identification of an invasion-inducing gene, Tiam1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 1994, 77:537-549.
17. Mertens A.E., Roovers R.C., Collard J.G. Regulation of Tiam1-Rac signalling. FEBS Lett 2003, 546:11-16.
18. Adam L., Vadlamudi R.K., McCrea P., Kumar R. Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/beta-catenin nuclear signaling in breast cancer cells by modulating the intercellular stability. J Biol Chem 2001, 276:28443-28450.
19. Lane J., Martin T.A., Mansel R.E., Jiang W.G. The expression and prognostic value of the guanine nucleotide exchange factors (GEFs) Trio, Vav1 and TIAM-1 in human breast cancer. Int Semin Surg Oncol 2008, 5:23.
20. Minard M.E., Herynk M.H., Collard J.G., Gallick G.E. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene 2005, 24:2568-2573.
21. Ding Y., Chen B., Wang S., Zhao L., Chen J., Chen L., et al. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients. Int J Cancer 2009, 124:653-658.
22. Stam J.C., Michiels F., van der Kammen R.A., Moolenaar W.H., Collard J.G. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. EMBO J 1998, 17:4066-4074.
23. Engers R., Springer E., Michiels F., Collard J.G., Gabbert H.E. Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J Biol Chem 2001, 276:41889-41897.
24. Fleming I.N., Gray A., Downes C.P. Regulation of the Rac1-specific exchange factor Tiam1 involves both phosphoinositide 3-kinase-dependent and -independent components. Biochem J 2000, 351:173-182.
25. Fleming I.N., Batty I.H., Prescott A.R., Gray A., Kular G.S., Stewart H., et al. Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1. Biochem J 2004, 382:857-865.
26. Lambert J.M., Lambert Q.T., Reuther G.W., Malliri A., Siderovski D.P., Sondek J., et al. Tiam1 mediates Ras activation of Rac by a PI (3)K-independent mechanism. Nat Cell Biol 2002, 4:621-625.
27. Misra S., Ghatak S., Zoltan-Jones A., Toole B.P. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 2003, 278:25285-25288.
28. Bourguignon L.Y., Spevak C.C., Wong G., Xia W., Gilad E. Hyaluronan-CD44 interaction with PKC-epsilon promotes oncogenic signaling by the stem cell marker, Nanog and the production of microRNA-21 leading to downregulation of the tumor suppressor protein, PDCD4, anti-apoptosis and chemotherapy resistance in breast tumor cells. J Biol Chem 2009, 284(39):26533-26546.
29. Ohashi R., Takahashi F., Cui R., Yoshioka M., Gu T., Sasaki S., et al. Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell. Cancer Lett 2007, 252:225-234.
30. Wang S.J., Bourguignon L.Y. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg 2006, 132:771-778.
31. Slomiany M.G., Dai L., Bomar P.A., Knackstedt T.J., Kranc D.A., Tolliver L., et al. Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. Cancer Res 2009, 69:4992-4998.
32. Cordo Russo R.I., Garcia M.G., Alaniz L., Blanco G., Alvarez E., Hajos S.E. Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway. Int J Cancer 2008, 122:1012-1018.
33. Bourguignon L.Y., Peyrollier K., Xia W., Gilad W.E. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 2008, 283:17635-17651.
34. Miletti-Gonzalez K.E., Chen S., Muthukumaran N., Saglimbeni G.N., Wu X., Yang J., et al. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res 2005, 65:6660-6667.
35. Colone M., Calcabrini A., Toccacieli L., Bozzuto G., Stringaro A., Gentile M., et al. The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?. J Invest Dermatol 2008, 128:957-971.
36. Lopes E.C., Garcia M.G., Vellon L., Alvarez E., Hajos S.E. Correlation between decreased apoptosis and multidrug resistance (MDR) in murine leukemic T cell lines. Leuk Lymphoma 2001, 42:775-787.
37. Alaniz L., Garcia M.G., Gallo-Rodriguez C., Agusti R., Sterin-Speziale N., Hajos S.E., et al. Hyaluronan oligosaccharides induce cell death through PI3-K/Akt pathway independently of NF-kappaB transcription factor. Glycobiology 2006, 16:359-367.
38. Staroselsky A.N., Mahlin T., Savion N., Klein O., Nordenberg J., Donin N., et al. Metastatic potential and multidrug resistance correlation in the B16 melanoma system. J Exp Ther Oncol 1996, 1:251-259.
39. Bjornland K., Lehne G., Johansen H.T., Fodstad O., Rugstad H.E., Aasen A.O., et al. Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells. Oncol Res 1998, 10:255-262.
40. Yang J.M., Vassil A., Hait W.N. Involvement of phosphatidylinositol-3-kinase in membrane ruffling induced by P-glycoprotein substrates in multidrug-resistant carcinoma cells. Biochem Pharmacol 2002, 63:959-966.
41. Bacso Z., Nagy H., Goda K., Bene L., Fenyvesi F., Matko J., et al. Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein. Cytometry A 2004, 61:105-116.
42. Lopes E.C., Ernst G., Aulicino P., Vanzulli S., Garcia M., Alvarez E., et al. Dissimilar invasive and metastatic behavior of vincristine and doxorubicin-resistant cell lines derived from a murine T cell lymphoid leukemia. Clin Exp Metastasis 2002, 19:283-290.
43. Lesley J., Hascall V.C., Tammi M., Hyman R. Hyaluronan binding by cell surface CD44. J Biol Chem 2000, 275:26967-26975.
44. Gál I., Lesley J., Ko W., Gonda A., Stoop R., Hyman R., et al. Role of the extracellular and cytoplasmic domains of CD44 in the rolling interaction of lymphoid cells with hyaluronan under physiologic flow. J Biol Chem 2003, 278:11150-11158.
45. Goldberg R.L., Seidman J.D., Chi-Rosso G., Toole B.P. Endogenous hyaluronante-cell surface interactions in 3T3 and simian virus-transformed 3T3 cells. J Biol Chem 1984, 259:9440-9446.
46. Toole B.P. Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res 2009, 15(24):7462-7468.
47. Bourguignon L.Y., Zhu H., Shao L., Chen Y.W. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem 2000, 275:1829-1838.
48. Garcia M.G., Alaniz L.D., Cordo Russo R.I., Alvarez E., Hajos S.E. PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines. Leuk Res 2009, 33:288-296.
49. Teranishi F., Takahashi N., Gao N., Akamo Y., Takeyama H., Manabe T., et al. Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo. Cancer Sci 2009, 100:770-777.
50. Strumane K., Song J.Y., Baas I., Collard J.G. Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiency. Leuk Res 2009, 32:113-120.